{
  "meta": {
    "title": "37_Non_Cell_Cycle_Specific_Cytotoxic_Drugs",
    "url": "https://brainandscalpel.vercel.app/37-non-cell-cycle-specific-cytotoxic-drugs-79aea944.html",
    "scrapedAt": "2025-11-30T06:59:55.215Z"
  },
  "questions": [
    {
      "id": 88377,
      "choices": [
        {
          "id": 214654,
          "text": "Aprepitant"
        },
        {
          "id": 214655,
          "text": "Mesna"
        },
        {
          "id": 214656,
          "text": "Ondansetron"
        },
        {
          "id": 214657,
          "text": "Metoclopramide"
        }
      ],
      "text": "Treatment for cisplatin induced delayed nausea and vomiting is:",
      "unique_key": "Q9294996",
      "question_audio": null,
      "question_video": null,
      "map_id": 34009152,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) which is a neurokinin-1 (NK1) receptor antagonist used to prevent delayed nausea and vomiting caused by chemotherapy agents like cisplatin. Delayed chemotherapy-induced nausea and vomiting (CINV) occurs more than 24 hours after chemotherapy administration and is primarily mediated by substance P acting on NK1 receptors in the central nervous system. Aprepitant works by blocking NK1 receptors, thereby preventing substance P from triggering nausea and vomiting. It is particularly effective when combined with other antiemetics like 5-HT3 receptor antagonists (e.g., ondansetron) and corticosteroids (e.g., dexamethasone) for optimal control of CINV. Explanation of Incorrect Options: Option B: Mesna (Incorrect) Mesna is a uroprotective agent used to prevent hemorrhagic cystitis caused by cyclophosphamide and ifosfamide. It has no role in preventing or treating chemotherapy-induced nausea and vomiting, making it incorrect for this question. Option C: Ondansetron (Incorrect) Ondansetron is a 5-HT3 receptor antagonist, which is highly effective for acute nausea and vomiting (occurring within 24 hours of chemotherapy administration). However, delayed nausea and vomiting is primarily mediated by substance P and NK1 receptors, not serotonin (5-HT3). Therefore, while ondansetron is useful for acute CINV, it is less effective for delayed-phase nausea and vomiting than aprepitant. Option D: Metoclopramide (Incorrect) Metoclopramide is a dopamine (D2) receptor antagonist with prokinetic and antiemetic properties, mainly used for gastroparesis and mild nausea. While high doses of metoclopramide have been used for CINV, they are less effective than NK1 receptor antagonists like aprepitant for delayed nausea and vomiting. Additionally, high-dose metoclopramide carries a risk of extrapyramidal side effects such as dystonia and tardive dyskinesia.",
      "correct_choice_id": 214654,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1761831700318663/1761831700318663.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/1761831700318663/1761831700318663.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88378,
      "choices": [
        {
          "id": 214658,
          "text": "Cisplatin"
        },
        {
          "id": 214659,
          "text": "Streptozocin"
        },
        {
          "id": 214660,
          "text": "Methysergide"
        },
        {
          "id": 214661,
          "text": "Cyclophosphamide"
        }
      ],
      "text": "Which of the following drugs is associated with untoward side effect of renal tubular damage:",
      "unique_key": "Q4457496",
      "question_audio": null,
      "question_video": null,
      "map_id": 34252401,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cisplatin. Cisplatin is a platinum-based chemotherapeutic agent known for its dose-limiting nephrotoxicity, particularly renal tubular damage. It primarily affects the proximal tubular cells of the kidney, leading to acute kidney injury (AKI), electrolyte imbalances (hypomagnesemia, hypokalemia), and long-term renal dysfunction. The nephrotoxicity occurs due to oxidative stress, inflammation, and apoptosis of renal tubular cells. To minimize renal damage, adequate hydration and administration of nephroprotective agents such as amifostine are used during therapy. Incorrect Options: (B) Streptozocin – Incorrect Streptozocin is an alkylating agent used mainly for pancreatic neuroendocrine tumors. It is selectively toxic to pancreatic beta cells, leading to diabetes mellitus rather than renal tubular damage. However, mild nephrotoxicity may be seen in some cases. (C) Methysergide – Incorrect Methysergide is a serotonin receptor antagonist used in the prevention of migraines. Its major adverse effect is retroperitoneal and cardiac fibrosis, not renal tubular damage. (D) Cyclophosphamide – Incorrect Cyclophosphamide is an alkylating agent used in chemotherapy and immunosuppression. While it can cause hemorrhagic cystitis due to its metabolite acrolein, it is not primarily associated with renal tubular damage. Hydration and Mesna (2-mercaptoethane sulfonate sodium) are used to prevent bladder toxicity.",
      "correct_choice_id": 214658,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/214841700319505/214841700319505.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/214841700319505/214841700319505.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88379,
      "choices": [
        {
          "id": 214662,
          "text": "Vinblastine"
        },
        {
          "id": 214663,
          "text": "Paclitaxel"
        },
        {
          "id": 214664,
          "text": "Cisplatin"
        },
        {
          "id": 214665,
          "text": "Bleomycin"
        }
      ],
      "text": "Which of the following chemotherapeutic agents is associated with secondary leukemia:",
      "unique_key": "Q3118689",
      "question_audio": null,
      "question_video": null,
      "map_id": 34361119,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cisplatin. Cisplatin, a platinum-based chemotherapeutic agent, has been linked to an increased risk of secondary leukemia, particularly therapy-related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia (t-AML). The risk is higher when cisplatin is used in combination with other DNA-damaging agents such as alkylating agents and topoisomerase II inhibitors. The mechanism involves DNA damage, chromosomal abnormalities, and impaired DNA repair, leading to the development of secondary malignancies after years of treatment. Incorrect Options: (A) Vinblastine – Incorrect Vinblastine is a vinca alkaloid that inhibits microtubule formation, leading to cell cycle arrest in metaphase. While it is associated with bone marrow suppression and neurotoxicity, it is not strongly linked to secondary leukemia. (B) Paclitaxel – Incorrect Paclitaxel is a taxane that stabilizes microtubules, preventing their depolymerization and thereby inhibiting mitosis. Although myelosuppression is a side effect, it does not significantly increase the risk of secondary leukemia. (D) Bleomycin – Incorrect Bleomycin is an antitumor antibiotic that induces DNA strand breaks. It is primarily associated with pulmonary toxicity (fibrosis) rather than secondary leukemia. Unlike alkylating agents and topoisomerase inhibitors, bleomycin has a lower risk of causing secondary malignancies.",
      "correct_choice_id": 214664,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11366921700319518/11366921700319518.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11366921700319518/11366921700319518.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88380,
      "choices": [
        {
          "id": 214666,
          "text": "Vincristine"
        },
        {
          "id": 214667,
          "text": "Paclitaxel"
        },
        {
          "id": 214668,
          "text": "Colchicine"
        },
        {
          "id": 214669,
          "text": "Etoposide"
        }
      ],
      "text": "Metaphase arrest is caused by all except :",
      "unique_key": "Q1676392",
      "question_audio": null,
      "question_video": null,
      "map_id": 34690515,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Etoposide. Unlike the other drugs listed, etoposide does not cause metaphase arrest. Instead, it inhibits topoisomerase II, leading to DNA strand breaks and preventing cells from progressing through the G2 phase and early mitosis, rather than specifically arresting them in metaphase. It is used for the treatment of small cell lung cancer, testicular cancer, and lymphomas. Incorrect Options: (A) Vincristine – Incorrect Vincristine is a vinca alkaloid that binds to tubulin, preventing microtubule formation and arresting cells in metaphase. It is used in the treatment of hematologic malignancies like leukemias and lymphomas. (B) Paclitaxel – Incorrect Paclitaxel is a taxane that stabilizes microtubules and prevents their depolymerization, leading to metaphase arrest. This prevents proper chromosome segregation and ultimately triggers apoptosis. It is used in breast, ovarian, and lung cancers. (C) Colchicine – Incorrect Colchicine binds to tubulin and prevents microtubule polymerization, leading to metaphase arrest. While it is primarily used for gout, its mechanism of action is similar to vinca alkaloids in disrupting mitotic spindle formation.",
      "correct_choice_id": 214669,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18104161700319599/18104161700319599.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18104161700319599/18104161700319599.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88381,
      "choices": [
        {
          "id": 214670,
          "text": "Gemcitabine"
        },
        {
          "id": 214671,
          "text": "5-FU"
        },
        {
          "id": 214672,
          "text": "Decitabine"
        },
        {
          "id": 214673,
          "text": "Homoharringotonine"
        }
      ],
      "text": "Which of the following anticancer drugs acts by hypomethylation:",
      "unique_key": "Q7841185",
      "question_audio": null,
      "question_video": null,
      "map_id": 34641334,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Decitabine. Decitabine is a DNA hypomethylating agent that works by inhibiting DNA methyltransferase (DNMT). This inhibition leads to hypomethylation of DNA, which reactivates tumor suppressor genes that had been silenced by hypermethylation. This mechanism is particularly useful in treating myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), where aberrant DNA methylation plays a crucial role in disease progression. Incorrect Options: (A) Gemcitabine – Incorrect Gemcitabine is a nucleoside analog that inhibits DNA synthesis by incorporating into the DNA strand and blocking replication. It does not affect DNA methylation. (B) 5-FU (Fluorouracil) – Incorrect 5-Fluorouracil (5-FU) is a pyrimidine analog that primarily inhibits thymidylate synthase (TS), leading to reduced DNA synthesis and repair. It does not act by hypomethylation. (D) Homoharringtonine – Incorrect Homoharringtonine (also known as Omacetaxine mepesuccinate) is a protein synthesis inhibitor that works by binding to the ribosome and blocking elongation of peptide chains. It is used in chronic myeloid leukemia (CML) but does not involve DNA hypomethylation.",
      "correct_choice_id": 214672,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62632021700319708/62632021700319708.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62632021700319708/62632021700319708.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88382,
      "choices": [
        {
          "id": 214674,
          "text": "Vinblastine"
        },
        {
          "id": 214675,
          "text": "Bleomycin"
        },
        {
          "id": 214676,
          "text": "Methotraxate"
        },
        {
          "id": 214677,
          "text": "Chlormabucil"
        }
      ],
      "text": "A 35-yr-old patient is having carcinoma lung with a past history of lung disease. All of the following drugs should be avoided except:",
      "unique_key": "Q5454735",
      "question_audio": null,
      "question_video": null,
      "map_id": 34023512,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Vinblastine. Vinblastine is a vinca alkaloid that acts by inhibiting microtubule formation, leading to mitotic arrest and apoptosis of cancer cells. While vinblastine can cause bone marrow suppression and neurotoxicity, it does not significantly cause pulmonary toxicity. Therefore, among the given options, it is the safest choice for a patient with pre-existing lung disease and carcinoma lung. Incorrect Options: (B) Bleomycin – Incorrect Bleomycin is highly pulmonary toxic and can lead to pulmonary fibrosis or bleomycin-induced lung injury (BILI). In patients with a history of lung disease, its use can significantly worsen respiratory function, increasing morbidity and mortality. (C) Methotrexate – Incorrect Methotrexate can cause interstitial pneumonitis and pulmonary fibrosis, which makes it dangerous in patients with pre-existing lung conditions. Chronic use can exacerbate lung disease and impair pulmonary function. (D) Chlorambucil – Incorrect Chlorambucil, an alkylating agent, can cause pulmonary fibrosis, particularly in prolonged use. Though less commonly associated with lung toxicity than bleomycin or methotrexate, it is still not ideal for a patient with lung disease.",
      "correct_choice_id": 214674,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37787901700319779/37787901700319779.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37787901700319779/37787901700319779.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88383,
      "choices": [
        {
          "id": 214678,
          "text": "Vinblastin"
        },
        {
          "id": 214679,
          "text": "Carmustine"
        },
        {
          "id": 214680,
          "text": "Actinomycin D"
        },
        {
          "id": 214681,
          "text": "Cyclophosphamide"
        }
      ],
      "text": "Sustained neutropenia is seen with :",
      "unique_key": "Q3404588",
      "question_audio": null,
      "question_video": null,
      "map_id": 34303484,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Carmustine. Carmustine, a nitrosourea class alkylating agent, is known for causing delayed and prolonged myelosuppression, leading to sustained neutropenia. Unlike other chemotherapy agents that cause acute myelosuppression, the effect of carmustine on the bone marrow is longer-lasting and can persist for 4–6 weeks. This delayed toxicity necessitates careful blood count monitoring and dose adjustments to prevent life-threatening neutropenia. Carmustine is commonly used in the treatment of brain tumors, Hodgkin’s lymphoma, and multiple myeloma. Incorrect Options: (A) Vinblastine – Incorrect Vinblastine, a vinca alkaloid, inhibits microtubule formation and primarily causes acute neutropenia rather than sustained neutropenia. Bone marrow suppression with vinblastine occurs early but typically resolves within a few days to a week, unlike carmustine, which has prolonged effects. (C) Actinomycin D – Incorrect Actinomycin D, an antitumor antibiotic, can cause bone marrow suppression, but it does not lead to sustained neutropenia. The neutropenia seen with actinomycin D is dose-dependent and reversible within a short period. (D) Cyclophosphamide – Incorrect Cyclophosphamide, an alkylating agent, can cause myelosuppression, but it does not lead to delayed and prolonged neutropenia like carmustine. The neutropenia caused by cyclophosphamide typically resolves within 10–14 days and is not as prolonged.",
      "correct_choice_id": 214679,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49957371700319827/49957371700319827.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49957371700319827/49957371700319827.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88384,
      "choices": [
        {
          "id": 214682,
          "text": "Vinblastine"
        },
        {
          "id": 214683,
          "text": "Dactinomycin"
        },
        {
          "id": 214684,
          "text": "Cyclophosphamide"
        },
        {
          "id": 214685,
          "text": "6-Mercaptopurine"
        }
      ],
      "text": "A patient with cancer developed extreme degree of radiation toxicity. Further history revealed that the dose adjustment of a particular drug was missed during the course of radiotherapy. Which of the following drugs required a those adjustment during radiotherapy in order to prevent radiation toxicity:",
      "unique_key": "Q2364288",
      "question_audio": null,
      "question_video": null,
      "map_id": 34426697,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Dactinomycin. Dactinomycin (Actinomycin D) is a cytotoxic antibiotic that intercalates DNA, inhibiting RNA synthesis and blocking transcription. It is highly radiosensitizing, meaning that it enhances the effects of radiation therapy, leading to an increased risk of severe radiation toxicity such as severe mucositis, skin reactions, and myelosuppression. Because of this, dose adjustments are necessary during radiotherapy to minimize potential toxicity. Incorrect Options (True Statements): (A) Vinblastine – Incorrect Vinblastine is a vinca alkaloid that disrupts microtubule polymerization, leading to mitotic arrest. Although it has myelosuppressive effects, it is not strongly radiosensitizing, and its dose does not require specific adjustment during radiotherapy. (C) Cyclophosphamide – Incorrect Cyclophosphamide is a nitrogen mustard alkylating agent that causes DNA cross-linking, leading to cell death. While it does cause myelosuppression, it is not known to significantly enhance radiation toxicity, so dose adjustment is generally not required during radiotherapy. (D) 6-Mercaptopurine – Incorrect 6-Mercaptopurine is a purine analog that interferes with DNA and RNA synthesis. It is myelosuppressive, but it does not have a significant radiosensitizing effect, meaning dose adjustment is not mandatory during radiotherapy.",
      "correct_choice_id": 214683,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13707271700319868/13707271700319868.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13707271700319868/13707271700319868.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88385,
      "choices": [
        {
          "id": 214686,
          "text": "Anthracycline"
        },
        {
          "id": 214687,
          "text": "Alkylating agent"
        },
        {
          "id": 214688,
          "text": "Platinum compound"
        },
        {
          "id": 214689,
          "text": "Bisphosphonates"
        }
      ],
      "text": "A 50 year old woman. Hema has been diagnosed with locally advanced breast cancer and recommended for chemotherapy. She has five years history of myocardial infarction and congestive heart failure. Which antineoplastic drug should be best avoided :",
      "unique_key": "Q6924252",
      "question_audio": null,
      "question_video": null,
      "map_id": 34631021,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Anthracycline. Anthracyclines (e.g., doxorubicin, daunorubicin, epirubicin) are potent antineoplastic agents used in the treatment of breast cancer and other malignancies. However, their use is associated with dose-dependent cardiotoxicity, including congestive heart failure (CHF), dilated cardiomyopathy, and irreversible myocardial damage. These effects are mediated through free radical formation and oxidative stress on cardiac myocytes, which lack sufficient protective enzymes like catalase. Given that this patient has a history of myocardial infarction (MI) and CHF, anthracyclines should be avoided to prevent worsening of her cardiac condition. Incorrect Options (True Statements): (B) Alkylating agents – Incorrect Alkylating agents (e.g., cyclophosphamide, ifosfamide) cause DNA cross-linking, leading to cancer cell death. While they may have some side effects like myelosuppression and hemorrhagic cystitis, they are not directly cardiotoxic and are safer than anthracyclines in this patient. (C) Platinum compounds – Incorrect Platinum-based drugs (e.g., cisplatin, carboplatin, oxaliplatin) exert their effect by cross-linking DNA strands, leading to apoptosis. They can cause nephrotoxicity and neurotoxicity, but they do not directly exacerbate CHF like anthracyclines do. (D) Bisphosphonates – Incorrect Bisphosphonates (e.g., zoledronic acid, pamidronate) are used to prevent bone metastasis and skeletal-related complications in breast cancer. They have no direct cardiotoxicity and are not contraindicated in patients with cardiac disease.",
      "correct_choice_id": 214686,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6838181700319882/6838181700319882.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6838181700319882/6838181700319882.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88386,
      "choices": [
        {
          "id": 214690,
          "text": "Cisplatin"
        },
        {
          "id": 214691,
          "text": "Nitrosourea"
        },
        {
          "id": 214692,
          "text": "Vincristine"
        },
        {
          "id": 214693,
          "text": "Vinblastine"
        }
      ],
      "text": "Which of the following anticancer drugs can cross blood brain barrier:",
      "unique_key": "Q7058931",
      "question_audio": null,
      "question_video": null,
      "map_id": 34944126,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Nitrosourea. Nitrosoureas (e.g., carmustine, lomustine, streptozocin) are unique among chemotherapy agents because they are highly lipophilic, allowing them to cross the blood-brain barrier (BBB) efficiently. Due to this property, they are commonly used in the treatment of brain tumors, such as glioblastomas and astrocytomas. They work by alkylating DNA, leading to cell cycle arrest and apoptosis. Their ability to penetrate the BBB makes them one of the few effective chemotherapy options for central nervous system (CNS) malignancies. Incorrect Options (True Statements): (A) Cisplatin – Incorrect Cisplatin is a platinum-based alkylating agent that works by forming DNA cross-links, leading to apoptosis. However, it has poor penetration into the BBB due to its hydrophilic nature. While it is effective for various cancers, including lung, ovarian, and testicular cancers, it is not suitable for primary brain tumors. (C) Vincristine – Incorrect Vincristine is a vinca alkaloid that works by inhibiting microtubule formation, leading to mitotic arrest. However, it does not cross the BBB effectively, making it ineffective for treating brain tumors. It is mainly used for hematologic malignancies like leukemia and lymphoma. (D) Vinblastine – Incorrect Like vincristine, vinblastine is a microtubule inhibitor, primarily used in Hodgkin's lymphoma and testicular cancer. It has poor BBB penetration, limiting its use in CNS malignancies.",
      "correct_choice_id": 214691,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33399561700319919/33399561700319919.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33399561700319919/33399561700319919.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88387,
      "choices": [
        {
          "id": 214694,
          "text": "Amifostine"
        },
        {
          "id": 214695,
          "text": "Folinic acid"
        },
        {
          "id": 214696,
          "text": "GM-CSF"
        },
        {
          "id": 214697,
          "text": "MESNA"
        }
      ],
      "text": "Toxicity of nitrogen mustards can be decreased by:",
      "unique_key": "Q2463540",
      "question_audio": null,
      "question_video": null,
      "map_id": 34981080,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor). GM-CSF is a hematopoietic growth factor that stimulates the proliferation and differentiation of bone marrow progenitor cells, particularly granulocytes and macrophages. Nitrogen mustards, such as cyclophosphamide, ifosfamide, and mechlorethamine, are known for causing dose-limiting bone marrow suppression, leading to neutropenia and increased risk of infections. By stimulating bone marrow recovery, GM-CSF helps mitigate the myelosuppressive toxicity of nitrogen mustard chemotherapy, making it an important supportive care agent. Incorrect Options (True Statements): (A) Amifostine – Incorrect Amifostine is a cytoprotective agent that is mainly used to reduce nephrotoxicity caused by cisplatin and xerostomia caused by radiation therapy. It does not significantly reduce the toxicity of nitrogen mustards, particularly their myelosuppressive effects. (B) Folinic Acid – Incorrect Also known as leucovorin, folinic acid is used to rescue normal cells from methotrexate toxicity by bypassing dihydrofolate reductase inhibition. However, it has no role in reducing the toxicity of nitrogen mustards. (D) MESNA – Incorrect MESNA (2-mercaptoethane sulfonate) is a uroprotective agent that is specifically used to prevent hemorrhagic cystitis caused by cyclophosphamide and ifosfamide. While it protects against bladder toxicity, it does not address bone marrow suppression, which is the primary toxicity of nitrogen mustards.",
      "correct_choice_id": 214696,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57057251700319931/57057251700319931.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57057251700319931/57057251700319931.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88388,
      "choices": [
        {
          "id": 214698,
          "text": "Cardiomyopathy"
        },
        {
          "id": 214699,
          "text": "Nephrotoxicity"
        },
        {
          "id": 214700,
          "text": "Neuropathy"
        },
        {
          "id": 214701,
          "text": "Tinnitus"
        }
      ],
      "text": "Cisplatin does not cause:",
      "unique_key": "Q5254758",
      "question_audio": null,
      "question_video": null,
      "map_id": 34880546,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cardiomyopathy. Cisplatin is a platinum-based chemotherapeutic agent widely used to treat various cancers, including testicular, ovarian, bladder, and lung cancers. It is known for its dose-limiting toxicities, but cardiomyopathy is not a typical side effect. Unlike anthracyclines (e.g., doxorubicin), which are well known for causing cardiotoxicity and heart failure, cisplatin primarily affects the kidneys, nervous system, and ears. Incorrect Options (True Statements): (B) Nephrotoxicity – Incorrect Cisplatin is highly nephrotoxic, leading to acute kidney injury (AKI) and chronic renal dysfunction due to damage to the proximal tubules. To minimize nephrotoxicity, aggressive hydration and diuretics (e.g., mannitol) are often used. (C) Neuropathy – Incorrect Cisplatin induces peripheral neuropathy, which manifests as numbness, tingling, and burning sensations in the extremities. This is a dose-dependent effect and can become irreversible with prolonged therapy. (D) Tinnitus – Incorrect Ototoxicity is a well-known side effect of cisplatin, causing tinnitus (ringing in the ears) and sensorineural hearing loss. Damage occurs in the cochlear hair cells, leading to progressive high-frequency hearing loss, which can be irreversible.",
      "correct_choice_id": 214698,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21663751700319955/21663751700319955.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21663751700319955/21663751700319955.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88389,
      "choices": [
        {
          "id": 214702,
          "text": "Vincristine"
        },
        {
          "id": 214703,
          "text": "Vinblastine"
        },
        {
          "id": 214704,
          "text": "Cisplatin"
        },
        {
          "id": 214705,
          "text": "Mitomycin-C"
        }
      ],
      "text": "Hemolytic uremic syndrome is adverse effect of :",
      "unique_key": "Q8889924",
      "question_audio": null,
      "question_video": null,
      "map_id": 34294646,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Mitomycin-C. Mitomycin-C is an antitumor antibiotic used in the treatment of various cancers, including bladder, gastrointestinal, and breast cancers. One of its serious adverse effects is hemolytic uremic syndrome (HUS), a condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury due to endothelial damage. Mitomycin-C causes direct vascular endothelial injury, leading to platelet aggregation and microthrombi formation, which result in hemolysis and renal failure. Incorrect Options (True Statements): (A) Vincristine – Incorrect Vincristine is a vinca alkaloid that primarily causes neurotoxicity, including peripheral neuropathy and autonomic dysfunction (e.g., constipation, ileus). However, it is not associated with hemolytic uremic syndrome. (B) Vinblastine – Incorrect Like vincristine, vinblastine is a microtubule inhibitor, primarily causing bone marrow suppression (myelosuppression) and mild neurotoxicity. It does not cause HUS. (C) Cisplatin – Incorrect Cisplatin is known for nephrotoxicity, neuropathy, and ototoxicity, but it does not typically cause HUS. Although it affects the kidneys, the mechanism is different from Mitomycin-C, as it leads to proximal tubular damage rather than microangiopathy.",
      "correct_choice_id": 214705,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51781651700319965/51781651700319965.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51781651700319965/51781651700319965.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88390,
      "choices": [
        {
          "id": 214706,
          "text": "G0"
        },
        {
          "id": 214707,
          "text": "G1"
        },
        {
          "id": 214708,
          "text": "G2"
        },
        {
          "id": 214709,
          "text": "M"
        }
      ],
      "text": "Which phase of the cell cycle is resistant to most chemotherapeutic agents, i.e., those that are classified as phase-specific?",
      "unique_key": "Q8193742",
      "question_audio": null,
      "question_video": null,
      "map_id": 34278334,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Explanation: The G0 phase (resting phase) is the most resistant to phase-specific chemotherapeutic agents because: Lack of Active Division: Cells in G0 are quiescent (not actively dividing), making them less susceptible to chemotherapy, which mainly targets rapidly dividing cells. Most Chemotherapy Targets Proliferating Cells: Phase-specific chemotherapeutic agents (e.g., antimetabolites, mitotic inhibitors) act on actively cycling cells in S-phase, G2-phase, or M-phase. Since G0 cells are dormant, these drugs have little effect on them. Resistance to DNA-Damaging Agents: Many alkylating agents and topoisomerase inhibitors require active DNA replication to exert their effects. G0 cells do not replicate DNA, making them resistant. Incorrect Option: (B) G1 Phase: Cells in G1 are preparing for DNA synthesis and can still be affected by drugs targeting DNA synthesis or the cell cycle. (C) G2 Phase: G2 phase is sensitive to drugs like bleomycin and etoposide, which affect DNA repair and mitotic entry. (D) M Phase: M-phase cells are highly susceptible to mitotic inhibitors (e.g., vincristine, paclitaxel), which disrupt microtubule function.",
      "correct_choice_id": 214706,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2547981700320221/2547981700320221.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2547981700320221/2547981700320221.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88391,
      "choices": [
        {
          "id": 214710,
          "text": "Capecitabine: Hand foot syndrome."
        },
        {
          "id": 214711,
          "text": "Ifosfamide: Hemorrhagic cystitis"
        },
        {
          "id": 214712,
          "text": "Mitomycin C: Hemolytic uremic syndrome"
        },
        {
          "id": 214713,
          "text": "Bleomycin: Renal Magnesium and calcium loss"
        }
      ],
      "text": "Which of the following is a wrong match with respect to the anticancer drug and its side effect?",
      "unique_key": "Q3507622",
      "question_audio": null,
      "question_video": null,
      "map_id": 34702066,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Bleomycin: Renal magnesium and calcium loss, as Bleomycin is not associated with significant renal magnesium and calcium loss. Instead, Bleomycin is well known for causing pulmonary toxicity, leading to pulmonary fibrosis, which is its most severe adverse effect. It works by generating free radicals that induce DNA strand breaks, making it an effective chemotherapeutic agent for testicular cancer, Hodgkin’s lymphoma, and squamous cell carcinomas. Unlike drugs like cisplatin, which cause renal electrolyte wasting, Bleomycin does not typically cause magnesium or calcium loss. Explanation of Incorrect Options: (A) Capecitabine: Hand-foot syndrome – Correct match. Capecitabine is an oral prodrug of 5-fluorouracil (5-FU) used in treating colorectal and breast cancers. A well-known side effect is hand-foot syndrome (palmar-plantar erythrodysesthesia), which presents as redness, swelling, pain, and peeling of the palms and soles. This occurs due to drug accumulation in the skin, leading to microvascular damage. (B) Ifosfamide: Hemorrhagic cystitis – Correct match. Ifosfamide, an alkylating agent, is known to cause hemorrhagic cystitis, characterized by bladder irritation, hematuria, and dysuria. This is due to the production of acrolein, a toxic metabolite that damages the bladder epithelium. Mesna (sodium 2-mercaptoethane sulfonate) is co-administered to neutralize acrolein and prevent hemorrhagic cystitis. (C) Mitomycin C: Hemolytic uremic syndrome (HUS) – Correct match. Mitomycin C, an antitumor antibiotic, is known to cause HUS, a condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. It damages vascular endothelial cells, leading to the formation of microthrombi, which cause intravascular hemolysis and renal failure.",
      "correct_choice_id": 214713,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43920381700320272/43920381700320272.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43920381700320272/43920381700320272.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88392,
      "choices": [
        {
          "id": 214714,
          "text": "Cyclophosphamide"
        },
        {
          "id": 214715,
          "text": "5-FU"
        },
        {
          "id": 214716,
          "text": "Enalapril"
        },
        {
          "id": 214717,
          "text": "Cyclophosphamide"
        }
      ],
      "text": "Which anti cancer drug is eliminated by lung:",
      "unique_key": "Q2646462",
      "question_audio": null,
      "question_video": null,
      "map_id": 34013229,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) 5-Fluorouracil (5-FU), as it is partially eliminated by the lungs through respiratory excretion as carbon dioxide. 5-FU is a pyrimidine analog that inhibits thymidylate synthase, disrupting DNA and RNA synthesis, leading to cell death. It is used in the treatment of colorectal, breast, gastric, and pancreatic cancers. 5-FU undergoes hepatic metabolism (via dihydropyrimidine dehydrogenase, DPD), and a portion of its metabolites is converted into carbon dioxide and excreted via the lungs. This pulmonary elimination pathway is unique among chemotherapeutic agents. Incorrect Options: (A) Cyclophosphamide Cyclophosphamide is a nitrogen mustard alkylating agent, primarily metabolized in the liver (CYP450 system) into active metabolites (e.g., phosphoramide mustard). These metabolites are excreted mainly through the kidneys (renal elimination), not the lungs. (C) Enalapril Enalapril is an angiotensin-converting enzyme (ACE) inhibitor, not an anticancer drug. It is metabolized in the liver into enalaprilat and excreted mainly by the kidneys. Although ACE inhibitors can cause a cough due to bradykinin accumulation in the lungs, they are not eliminated via the lungs. (D) Cyclophosphamide As mentioned earlier, cyclophosphamide is not eliminated via the lungs but rather through the kidneys.",
      "correct_choice_id": 214715,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13544261700320344/13544261700320344.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13544261700320344/13544261700320344.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88393,
      "choices": [
        {
          "id": 214718,
          "text": "Methotrexate"
        },
        {
          "id": 214719,
          "text": "Tamoxifen"
        },
        {
          "id": 214720,
          "text": "Cyclophosphamide"
        },
        {
          "id": 214721,
          "text": "Doxorubicin"
        }
      ],
      "text": "Which of the following is an alkylating agent used in cancer chemotherapy?",
      "unique_key": "Q6307493",
      "question_audio": null,
      "question_video": null,
      "map_id": 34521135,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cyclophosphamide. Cyclophosphamide is a nitrogen mustard alkylating agent used in cancer chemotherapy. It exerts its cytotoxic effects by cross-linking DNA strands, leading to DNA damage, inhibition of replication, and apoptosis of rapidly dividing cancer cells. Alkylating agents are cell cycle–nonspecific, meaning they can affect cancer cells at any phase of the cell cycle. Cyclophosphamide is used to treat a variety of malignancies, including leukemias, lymphomas, breast cancer, and ovarian cancer. Additionally, it has immunosuppressive properties, making it useful in autoimmune conditions such as lupus nephritis. However, cyclophosphamide has significant side effects, including myelosuppression, hemorrhagic cystitis (due to acrolein, a toxic metabolite), and secondary malignancies. To prevent hemorrhagic cystitis, mesna is often co-administered to neutralize acrolein in the bladder. Explanation of Incorrect Options: (A) Methotrexate: Methotrexate is an antimetabolite that inhibits dihydrofolate reductase (DHFR), leading to impaired thymidylate and purine synthesis. This disrupts DNA synthesis, primarily affecting rapidly dividing cells in the S phase of the cell cycle. It is used for leukemia, lymphoma, breast cancer, and autoimmune diseases, but it is not an alkylating agent. (B) Tamoxifen: Tamoxifen is a selective estrogen receptor modulator (SERM), used mainly in estrogen receptor (ER)-positive breast cancer. It acts as an estrogen antagonist in breast tissue while having partial agonist effects in the uterus and bones. Unlike cyclophosphamide, tamoxifen does not directly damage DNA and is not an alkylating agent. (D) Doxorubicin: Doxorubicin is an anthracycline antibiotic that exerts its anticancer effects by intercalating into DNA, inhibiting topoisomerase II, and generating free radicals, leading to DNA strand breaks and apoptosis. It is used in treating a wide range of cancers, including breast cancer, lymphoma, and sarcomas, but it is not an alkylating agent. Its major toxicity is cardiotoxicity, which can lead to dilated cardiomyopathy.",
      "correct_choice_id": 214720,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 88394,
      "choices": [
        {
          "id": 214722,
          "text": "Hypoglycemia"
        },
        {
          "id": 214723,
          "text": "Nephrotoxicity"
        },
        {
          "id": 214724,
          "text": "Osteoporosis"
        },
        {
          "id": 214725,
          "text": "Hyperlipidemia"
        }
      ],
      "text": "A 50-year-old patient with non-small cell lung cancer is being treated with cisplatin. Which of the following side effects is most commonly associated with this drug?",
      "unique_key": "Q4918713",
      "question_audio": null,
      "question_video": null,
      "map_id": 34107292,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Cisplatin is most commonly associated with nephrotoxicity (Option B), which is the correct answer. Cisplatin is a platinum-based chemotherapeutic agent used to treat various cancers, including non-small cell lung cancer (NSCLC), ovarian cancer, and testicular cancer. Its nephrotoxicity arises due to its accumulation in renal tubular cells, causing acute tubular necrosis (ATN) and leading to renal dysfunction. This effect is dose-dependent and can manifest as elevated serum creatinine, electrolyte imbalances (hypomagnesemia, hypokalemia), and reduced glomerular filtration rate (GFR). Adequate hydration, electrolyte supplementation, and administration of amifostine (a cytoprotective agent) can help mitigate nephrotoxicity. Explanation of Incorrect Options: (A) Hypoglycemia: Cisplatin is not known to cause hypoglycemia. While chemotherapy can sometimes lead to metabolic disturbances, hypoglycemia is not a primary side effect of cisplatin. Hypoglycemia is more commonly seen with insulin, sulfonylureas, and insulinomas, rather than platinum-based chemotherapy. (C) Osteoporosis: Cisplatin is not directly linked to osteoporosis. Some cancer treatments, such as hormonal therapy (e.g., aromatase inhibitors for breast cancer or androgen deprivation therapy for prostate cancer), corticosteroids, and radiation therapy, can increase the risk of osteoporosis, but cisplatin does not have a significant effect on bone density. (D) Hyperlipidemia: Cisplatin does not typically affect lipid metabolism. Chemotherapy-induced metabolic changes can occur, but hyperlipidemia is more commonly associated with long-term corticosteroid use, obesity, and metabolic syndrome, rather than cisplatin therapy.",
      "correct_choice_id": 214723,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}